SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Engineering cancer dormancy as a collective emergent phenomenon: from matrix-enabled dormancy to collective dormancy-on-a-chip

DORMATRIX aims to engineer breast cancer dormancy as a collective emergent phenomenon using biomaterials-based devices to delay or prevent metastatic growth through advanced modeling and imaging.

Subsidie
€ 2.349.943
2024

Projectdetails

Introduction

Cancer dormancy and the trigger to transition to active metastatic growth is a big open question. Current in vivo models focus on niche-specific cell and molecular mechanisms, ignoring biophysical aspects. Dormancy evolves with complex spatio-temporal dynamics; yet, there is a knowledge gap in the understanding of the heterogeneity of the units, and the dynamics of their interaction and evolution.

Emergence of Macro-Level Organization

Emergence occurs when a critical mass of units synergistically communicates, giving rise to a new macro-level organization, with properties greater than the sum of the units. Engineering emergent phenomena in biological systems is a big research challenge as they originate from multiscale communication.

DORMATRIX Proposal

In DORMATRIX, I propose a radically new view. I hypothesize that the balance between cancer dormancy and “awakening” is a collective emergent phenomenon, whereby a critical mass of micro-units communicates with each other and the environment in order to transition to metastatic growth.

Objectives of DORMATRIX

The main objective of DORMATRIX is to engineer breast cancer (BC) dormancy as a collective emergent phenomenon using biomaterials-based dormancy-on-a-chip devices.

Previous Findings

My previous data shows that we can:

  1. Apply biophysical cues to control BC proliferation.
  2. Visualize in vivo early BC bone metastasis.

Multidisciplinary Approach

I will now address this outstanding challenge with a multidisciplinary approach:

  1. Apply biophysical principles with novel biomaterials to model in vitro cancer micro-units.
  2. Develop advanced 3D imaging to visualize collective cancer dormancy and bone microdamage.
  3. Develop in silico models based on evolutionary game theory to predict the dynamics.
  4. Prove my hypothesis with dormancy-on-a-chip devices.

Future Implications

Understanding the critical mass and multiscale communication required for emergent phenomena will enable the development of novel therapies to delay or prevent metastasis. The resulting technology for engineering emergent phenomena will spark research on other biological systems.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.349.943
Totale projectbegroting€ 2.349.943

Tijdlijn

Startdatum1-10-2024
Einddatum30-9-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • ASOCIACION INSTITUTO DE INVESTIGACION SANITARIA BIOGIPUZKOApenvoerder

Land(en)

Spain

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Mechanobiology of cancer progression

This project aims to develop an innovative in vivo platform to study tumor fibrosis and improve targeted cancer therapies by mimicking the fibrotic microenvironment of breast cancer.

ERC Advanced...€ 2.498.690
2022
Details

Propagation of cellular memory through dormancy

DOR-CODE aims to uncover the genomic mechanisms of embryonic dormancy to enhance understanding of cellular identity propagation and improve embryo preservation techniques.

ERC Starting...€ 1.488.750
2024
Details

COmputational DEsign for 4D BIOfabrication: harnessing programmable materials for dynamic pre-clinical cancer models

CoDe4Bio aims to revolutionize cancer research by developing programmable 4D biofabricated models to better understand dynamic physical cues and improve pre-clinical drug screening.

ERC Starting...€ 1.495.100
2023
Details

Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug Penetration

This project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes.

ERC Starting...€ 1.499.693
2024
Details

Regaining control of cancer at biological borders

BorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis.

ERC Advanced...€ 2.500.000
2024
Details
ERC Advanced...

Mechanobiology of cancer progression

This project aims to develop an innovative in vivo platform to study tumor fibrosis and improve targeted cancer therapies by mimicking the fibrotic microenvironment of breast cancer.

ERC Advanced Grant
€ 2.498.690
2022
Details
ERC Starting...

Propagation of cellular memory through dormancy

DOR-CODE aims to uncover the genomic mechanisms of embryonic dormancy to enhance understanding of cellular identity propagation and improve embryo preservation techniques.

ERC Starting Grant
€ 1.488.750
2024
Details
ERC Starting...

COmputational DEsign for 4D BIOfabrication: harnessing programmable materials for dynamic pre-clinical cancer models

CoDe4Bio aims to revolutionize cancer research by developing programmable 4D biofabricated models to better understand dynamic physical cues and improve pre-clinical drug screening.

ERC Starting Grant
€ 1.495.100
2023
Details
ERC Starting...

Personalised Mechanobiological Models to Predict Tumour Growth and Anti-Cancer Drug Penetration

This project aims to develop a personalized cancer treatment framework by modeling stress-dependent tumor growth and drug penetration to enhance patient-specific therapy outcomes.

ERC Starting Grant
€ 1.499.693
2024
Details
ERC Advanced...

Regaining control of cancer at biological borders

BorderControl aims to identify molecular signals and mechanisms that enable cancer cells to breach physiological barriers, with the goal of uncovering novel biomarkers and therapeutic targets for metastasis.

ERC Advanced Grant
€ 2.500.000
2024
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

3D spheroids derived from single cells for discovering stochastic patterns behind metastasis

3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.

EIC Pathfinder€ 2.591.050
2023
Details

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

EIC Pathfinder€ 2.982.792
2022
Details
EIC Pathfinder

3D spheroids derived from single cells for discovering stochastic patterns behind metastasis

3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.

EIC Pathfinder
€ 2.591.050
2023
Details
EIC Pathfinder

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

EIC Pathfinder
€ 2.982.792
2022
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.